MarketCap
Facebook
X
TelegramZIOPHARM Oncology, Inc. Finanzkreislauf | ZIOP
Finanzkreislauf Jährlich ZIOPHARM Oncology, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 63.5 | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.5 | 63.5 | 63.5 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Teligent, Inc.
TLGT
|
120 | - | -13.85 % | $ 16.1 M |  USA |
 |
Viela Bio, Inc.
VIE
|
139 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
556 | $ 65.76 | 2.33 % | $ 9.49 B | USA |
 |
Aphria Inc.
APHA
|
96.5 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Chiasma, Inc.
CHMA
|
7.55 | - | -6.00 % | $ 238 M | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
59.1 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
55 | - | 0.38 % | $ 12.9 M |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-206 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
1.98 | - | -1.68 % | $ 283 M | USA |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
26.4 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
52.8 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
64.6 | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
3.92 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
470 | - | - | $ 256 M | Canada |
 |
XBiotech
XBIT
|
-1.26 K | $ 1.95 | -1.02 % | $ 59.5 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
464 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
16.2 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
-30.4 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
87 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
122 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
-1.84 K | $ 1.87 | 3.68 % | $ 3.18 M | USA |
 |
Viridian Therapeutics
VRDN
|
18 | $ 31.22 | 1.17 % | $ 3.18 B | USA |
 |
Translate Bio, Inc.
TBIO
|
53.1 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
246 | - | - | $ 1.94 B | Canada |
 |
Urovant Sciences Ltd.
UROV
|
25.3 | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
319 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
9.2 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
4 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
4 | - | 0.10 % | $ 92.2 M |  China |
 |
Vanda Pharmaceuticals
VNDA
|
136 | $ 4.17 | 2.08 % | $ 246 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
27.2 | $ 3.88 | 10.23 % | $ 41.3 M | USA |
 |
Zymeworks
ZYME
|
211 | $ 29.06 | -7.64 % | $ 1.5 B | Canada |
 |
ADMA Biologics
ADMA
|
355 | $ 13.19 | 4.1 % | $ 3.14 B | USA |
 |
Daré Bioscience
DARE
|
-1.64 K | $ 0.71 | 2.5 % | $ 7.94 M | USA |
 |
Fate Therapeutics
FATE
|
122 | $ 1.6 | -9.6 % | $ 190 M | USA |
 |
Halozyme Therapeutics
HALO
|
322 | $ 101.68 | -1.26 % | $ 12.2 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
95.8 | $ 15.09 | -1.92 % | $ 13 B | China |
 |
Aptorum Group Limited
APM
|
-2.57 K | - | - | $ 5.72 M | China |